Utilize the proprietary reagents along with the Quanterix Homebrew Assay Kit to develop a rapid prototype Simoa® assay that offers greater sensitivity and ease of use compared to ELISA.

Molecular diagnostic assay development and design is no simple task, and several factors affect the performance and usability of a test. Diagnostic companies can enhance assay stability and ...

A commercialization model using commercial kits/assays is proposed. Perhaps this model holds the most promise for standardizing the molecular tests since the commercial assays provide standardized ...

The Molecular Diagnostic and Assay Development Hub is focused on expanding our targeted and agnostic diagnostic capabilities against viral threats with pandemic potential. During the two-year start-up ...

Bio-Techne Corporation announced that Asuragen, a Bio-Techne brand, launched a highly sensitive ESR1 mutation monitoring assay. ESR1 gene mutations are known to be linked to hormone receptor-positive ...

The Cyto-Cellect® Fc Fusion assay kit expands on Sphere Fluidics’ existing portfolio of Cyto-Cellect® assays, offering unique capabilities for researchers to streamline their workflows in cell line ...

But researchers have now developed an assay that can diagnose highly pathogenic H5N1 avian ... can promptly adapt to virus mutation to prevent the spread of infection. The kit developed in our joint ...

HTRF KinEASE TK kit is available ... for the detection of molecular interactions of proteins in vitro. A universal kinase platform HTRF KinEASE screenings limit assay development time and are ...

The regulation of molecular diagnostics will play an important role in determining the availability of new assays. Existing regulatory regimes did not contemplate the advent of molecular ...

Dr. James Dunn will join us to discuss the process for the practical implementation of multiplex molecular assays for infectious diseases at different points of service. Throughout the session, Dr.

Bio-Techne Corp. TECH has launched a highly sensitive ESR1 mutation monitoring assay through its Asuragen brand. ESR1 gene mutations are known to be linked to hormone receptor-positive (HR+) ...